Form 8-K · Current report
IBM 8-K, filed Jul 22, 2026
- Filed
- CIK
- 0000051143
- Accession no.
- 0000051143-26-000077
Summary
IBM announced its second-quarter 2026 earnings results, reporting GAAP revenue of $17.2 billion and maintaining its strategy focused on growth in AI and enterprise solutions. The company updated its full-year guidance to expect constant currency revenue growth in the range of 4-5%, and announced a $10 billion commitment over the next five years to accelerate quantum computing development.
Key points
- IBM expects full-year constant currency revenue growth in the range of four-to-five percent.
- The company is investing more than $10 billion over the next five years into quantum computing, including building Anderon with the U.S. Department of Commerce.
- Software revenues increased 5% in the second quarter, with Hybrid Cloud and Data segments showing significant growth.
- The board approved a regular quarterly cash dividend of $1.69 per common share, continuing a streak dating back to 1916.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. The registrant’s press release dated July 22, 2026, regarding its financial results for the period ended June 30, 2026, including consolidated financial statements for the period ended June 30, 2026, is Exhibit 99.1 of this Form 8-K. In an effort to provide investors with additional information regarding the company’s results as determined by generally accepted accounting principles (GAAP), the company has disclosed in the attached press release certain non-GAAP information which management believes provides useful information to investors. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.